 Anti-Asthmatic Agents
"Anti-Asthmatic Agents" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Drugs that are used to treat asthma.
| Descriptor ID |
D018927
|
| MeSH Number(s) |
D27.505.954.796.050
|
| Concept/Terms |
Anti-Asthmatic Agents- Anti-Asthmatic Agents
- Agents, Anti-Asthmatic
- Anti Asthmatic Agents
- Anti-Asthmatics
- Anti Asthmatics
- Antiasthmatic Drugs
- Drugs, Antiasthmatic
- Antiasthmatics
- Anti-Asthmatic Drugs
- Anti Asthmatic Drugs
- Drugs, Anti-Asthmatic
- Antiasthmatic Agents
- Agents, Antiasthmatic
|
Below are MeSH descriptors whose meaning is more general than "Anti-Asthmatic Agents".
Below are MeSH descriptors whose meaning is more specific than "Anti-Asthmatic Agents".
This graph shows the total number of publications written about "Anti-Asthmatic Agents" by people in this website by year, and whether "Anti-Asthmatic Agents" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 1 | 2 | 3 | | 2001 | 2 | 0 | 2 | | 2002 | 2 | 0 | 2 | | 2003 | 4 | 1 | 5 | | 2004 | 4 | 2 | 6 | | 2005 | 4 | 1 | 5 | | 2006 | 7 | 2 | 9 | | 2007 | 3 | 3 | 6 | | 2008 | 3 | 8 | 11 | | 2009 | 4 | 2 | 6 | | 2010 | 4 | 2 | 6 | | 2011 | 4 | 4 | 8 | | 2012 | 2 | 6 | 8 | | 2013 | 5 | 3 | 8 | | 2014 | 3 | 2 | 5 | | 2015 | 5 | 1 | 6 | | 2016 | 8 | 4 | 12 | | 2017 | 8 | 4 | 12 | | 2018 | 10 | 3 | 13 | | 2019 | 7 | 1 | 8 | | 2020 | 7 | 0 | 7 | | 2021 | 7 | 1 | 8 | | 2022 | 9 | 0 | 9 | | 2023 | 9 | 0 | 9 | | 2024 | 8 | 7 | 15 | | 2025 | 18 | 1 | 19 | | 2026 | 6 | 1 | 7 |
To return to the timeline, click here.
Below are the most recent publications written about "Anti-Asthmatic Agents" by people in Profiles.
-
Ngo SY, Anderson WC. Using Asthma Phenotypes and Endotypes to Guide Treatment in Pediatric Asthma. Immunol Allergy Clin North Am. 2026 Nov; 46(4):615-630.
-
Lugogo NL, Peters AT, Katial R, Chen C, Song X, Soliman M, Kwah J, Subramaniam A, Tardy AL, Wang Z. High systemic corticosteroids burden among patients with moderate-to-severe asthma in the United States. Ann Allergy Asthma Immunol. 2026 Nov; 137(5):579-587.e5.
-
Wechsler ME, Wenzel SE, Groshong SD, Castro M, Pavord ID, Rabe KF, Laws E, Jagerschmidt A, Gayvert K, Harel S, Hamilton JD, Amin N, Zhang L, Xing H, Elfakir A, Coulibaly B, Naimi S, Hamon S, Rowe PJ, Nestle F, Cunoosamy DM, de Rinaldis E, Mannent LP. Effect of Dupilumab on Airway Inflammation in Patients With Persistent Asthma. Allergy. 2026 Sep; 81(9):3261-3272.
-
Andoh AA, Tanverdi MS, Shapiro DJ, Lipshaw MJ, Cushing AM, Olsen CS, Meeks HD, Morris K, Leonard JC, Zorc JJ. Variations in Corticosteroids Used for Asthma Exacerbations in the Pediatric Emergency Department: A Pediatric Emergency Care Applied Research Network Registry Study. J Allergy Clin Immunol Pract. 2026 Jun; 14(6):1363-1372.e2.
-
Davis AE, Rhoads S, Wechsler ME. Emerging biologic targets in type 2 and non-type 2 asthma. Curr Opin Pulm Med. 2026 May 01; 32(3):210-219.
-
Ologundudu LM, Wong MM, Islam N, Rayner DG, Chu AWL, Loeb M, Rivera-Spoljaric K, Chipps B, Sumino K, Oppenheimer J, Nyenhuis SM, Israel E, Hoyte F, Perry TT, McCabe E, Press VG, Rangel S, Guyatt GH, Shade LE, O'Byrne PM, Orr H, Sue-Wah-Sing D, Melendez A, Winders T, Gardner DD, Przywara K, Mosnaim G, Bacharier LB, Rank MA, Chu DK. Macrolides for asthma: A systematic review and meta-analysis of randomized trials. J Allergy Clin Immunol. 2026 Oct; 158(4):970-981.
-
Chopra P, Anderson Iii WC. Biologics in Pediatric Asthma: Controlling Symptoms, Maintaining Safety, and Improving Outcomes. Curr Allergy Asthma Rep. 2026 Feb 04; 26(1):8.
-
Oberle AJ, Abbas F, Adrish M, Agache I, Conroy M, Coz Yataco AO, Little FF, Mammen MJ, Anand MP, Reddy R, Solanki N, Holguin F. Biologic Management in Severe Asthma for Adults: An American College of Chest Physicians Clinical Practice Guideline. Chest. 2026 Feb; 169(2):336-348.
-
Tomasello A, Szefler SJ, Cahill KN. Emerging Systemic Treatments for Asthma and Allergic Diseases: New Tricks, Same Dog? J Allergy Clin Immunol Pract. 2026 02; 14(2):325-335.
-
Harvey ES, Hamada Y, Hiles SA, Langton D, Thomas D, McDonald VM, Bardin P, Peters M, Reynolds PN, Upham JW, Blakey J, Bowler S, Chien J, Chung LP, Farah CS, Gillman A, Harrington J, Hew M, Jenkins C, Katelaris CH, Katsoulotos GP, Kritikos V, Lee J, Radhakrishna N, Sivakumaran P, Wark PAB, Gibson PG. Mepolizumab treatment and reduced oral corticosteroid exposure improves symptoms of depression and anxiety in severe eosinophilic asthma: data from the Australian Mepolizumab Registry. Respir Med. 2025 11; 248:108340.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|